We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock
VYNT

Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

13 hedge funds and large institutions have $597K invested in Vyant Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

28% less funds holding

Funds holding: 18 → 13 (-5)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

66% less capital invested

Capital invested by funds: $1.73M → $597K (-$1.14M)

Holders
13
Holders Change
-5
Holders Change %
-27.78%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
1
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$2.72K
2
AIC
Ameritas Investment Company
Nebraska
+$406
3
Wells Fargo
Wells Fargo
California
+$41

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$141K
2
LI
Leap Investments
Illinois
-$116K
3
Millennium Management
Millennium Management
New York
-$64K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$60K
5
Renaissance Technologies
Renaissance Technologies
New York
-$28.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$443K -$28.8K -1,418 -4%
BlackRock
2
BlackRock
New York
$101K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$29K – – –
UBS Group
4
UBS Group
Switzerland
$8K -$670 -33 -5%
Wells Fargo
5
Wells Fargo
California
$5K +$41 +2 +0.5%
FPB
6
First PREMIER Bank
South Dakota
$3K – – –
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$3K – – –
Victory Capital Management
8
Victory Capital Management
Texas
$2K +$2.72K +134 New
Fifth Third Bancorp
9
Fifth Third Bancorp
Ohio
$1K – – –
MC
10
Mayo Clinic
Minnesota
$1K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$1K +$873 +43 New
OAM
12
Oxford Asset Management
United Kingdom
– -$141K -4,716 Closed
LI
13
Leap Investments
Illinois
– -$116K -3,904 Closed
Millennium Management
14
Millennium Management
New York
– -$64K -2,163 Closed
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
– -$60K -2,000 Closed
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
– -$20K -672 Closed
AIC
17
Ameritas Investment Company
Nebraska
– +$406 +20 New

VYNT Hedge Fund Activity: Q1 2020 in Review

13 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2020, worth a combined $597K — down 66% from $1.73M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VYNT and 3 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $2.72K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $141K sold.

  • 13 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2020, down from 18 in Q4 2019.
  • Funds reported $597K of Vyant Bio, Inc. Common Stock stock for Q1 2020, down 66% quarter-over-quarter.
  • 3 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2020 and 7 closed out, a net change of -4 holders.
  • The largest Vyant Bio, Inc. Common Stock buyer in Q1 2020 was Victory Capital Management, an estimated $2.72K added.
  • The largest Vyant Bio, Inc. Common Stock seller in Q1 2020 was Oxford Asset Management, an estimated $141K sold.

Based on aggregated 13F filings for Q1 2020.